More than 31,000 units of a chemotherapy drug are being recalled by manufacturer Bristol-Myers Squibb Co., because one vial was found to be overfilled, which puts patients at risk for overdose. The recall affects 10 lots of BiCNU, an injection of the drug carmustine, which is used to treat brain tumors, multiple myeloma, Hodgkin’s disease and non-Hodgkin’s lymphoma. An overdose of BiCNU could result in lung or kidney toxicity. No adverse events have yet been reported.
BiCNU was manufactured by Ben Venue Laboratories, a manufacturing contractor that Bristol-Myers Squibb no longer uses. The recall affects products sold in the United States, Canada, Europe, Latin America and Asia.
Carmustine is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in the body. Bristol-Myers Squibb said the recall is unlikely to result in a product shortage.
Customers and health care professionals with questions can get more information by calling the drug company at 1-888-896-4564.
Source: Pharm Pro